Infant formula brand developed at Tufts, marketed by Abbott
The Department of Justice has reached a settlement with Abbott over concerns about a Michigan plant that produced a major share of the U.S. infant formula supply. Regulators cite unsanitary conditions; Abbott reports no admission of fault and notes negative tests on unopened product from infants’ homes. The deal directs corrective steps and allocates funds to regulators and whistle-blowers.